Skip to main content

Almotriptan Cinfa 12,5 mg comprimidos recubiertos con película

Prescription request online

Prescription request online

A doctor will review your case and decide whether a prescription is medically appropriate.

Talk to a doctor about this medicine

Talk to a doctor about this medicine

Discuss your symptoms and possible next steps in a quick online consultation.

This page is for general information. Consult a doctor for personal advice. Call emergency services if symptoms are severe.
About the medicine

How to use ALMOTRIPTAN CINFA 12.5 mg FILM-COATED TABLETS

Contents of the leaflet

  1. Introduction
  2. What is almotriptán cinfa and what is it used for
  3. What you need to know before taking almotriptán cinfa
  4. How to take almotriptán cinfa
  5. Possible side effects
  6. Storage of almotriptán cinfa
  7. Contents of the pack and further information

Introduction

Package Leaflet: Information for the User

almotriptán cinfa 12.5 mg film-coated tablets EFG

Read the entire package leaflet carefully before starting to take this medication, as it contains important information for you.

  • Keep this package leaflet, as you may need to read it again.
  • If you have any questions, consult your doctor, pharmacist, or nurse.
  • This medication has been prescribed to you only, and you should not give it to others, even if they have the same symptoms as you, as it may harm them.
  • If you experience side effects, consult your doctor, pharmacist, or nurse, even if they are not mentioned in this package leaflet. See section 4.

Contents of the Package Leaflet:

  1. What is almotriptán cinfa and what is it used for.
  2. What you need to know before taking almotriptán cinfa.
  3. How to take almotriptán cinfa.
  4. Possible side effects.
  5. Storage of almotriptán cinfa.
  6. Contents of the pack and further information.

1. What is almotriptán cinfa and what is it used for

Almotriptán cinfa is an antimigraine medication that belongs to a class of compounds known as selective serotonin receptor agonists. It is believed that almotriptán cinfa reduces the inflammatory response associated with migraines by binding to serotonin receptors in cerebral blood vessels (cranial), causing vasoconstriction.

Almotriptán cinfa is used to relieve headache pain associated with migraine attacks with or without aura.

Doctor consultation

Not sure if this medicine is right for you?

Discuss your symptoms and treatment with a doctor online.

2. What you need to know before taking almotriptán cinfa

Do not take almotriptán cinfa

  • If you are allergic to almotriptán or any of the other ingredients of this medication (listed in section 6).
  • If you have or have ever had any disease that limits blood flow to the heart, such as:
  • Myocardial infarction.
  • Chest pain or discomfort that occurs normally after physical activity or stress.
  • Painless cardiac problems.
  • Chest pain that occurs at rest.
  • Severe hypertension (very high blood pressure).
  • Uncontrolled, mild, or moderate hypertension.
  • If you have had a stroke or a reduction in cerebral blood flow.
  • If you have had an obstruction of the large arteries of the arms or legs (peripheral vascular disease).
  • If you are taking other medications to combat migraines, including ergotamine, dihydroergotamine, and methysergide or another selective serotonin agonist (e.g., sumatriptan).
  • If you have severe liver problems.

Warnings and precautions

Consult your doctor, pharmacist, or nurse before starting to take almotriptán cinfa:

  • If your type of migraine has not been diagnosed.
  • If you are allergic (hypersensitive) to antibacterial medications used to treat urinary tract infections (sulfonamides).
  • If the symptoms of your headache are different from those of your usual migraine attacks, for example, you hear noise in your ears or feel dizzy, you have a brief paralysis of a part of your body or paralysis of the muscles that control your eye movements, or any other new symptoms.
  • If you are at risk of having heart disease, including high blood pressure and uncontrolled cholesterol, obesity, diabetes, smoking, family history of heart disease, postmenopausal women, or men over 40 years old.
  • If you have mild or moderate liver problems.
  • If you have severe kidney problems.
  • If you are over 65 years old, as you are more likely to experience increased blood pressure.
  • If you are taking antidepressants (SSRIs) or serotonin and norepinephrine reuptake inhibitors (SNRIs). See also below, Taking almotriptán cinfa with other medications.

It has been suggested that excessive use of antimigraine medications may lead to chronic headache.

Children and adolescents

Children under 18 years old should not take this medication.

Patientsof advanced age (over 65 years old)

If you are over 65 years old, you should consult your doctor before taking this medication.

Other medications and almotriptán cinfa

Tell your doctor or pharmacist if you are taking, have recently taken, or may need to take any other medication.

Please inform your doctor:

  • If you are taking any medication for depression, such as monoamine oxidase inhibitors (e.g., moclobemide), selective serotonin reuptake inhibitors (e.g., fluoxetine), or serotonin and norepinephrine reuptake inhibitors (e.g., venlafaxine), as these medications may cause serotonin syndrome, a potentially very serious treatment reaction. The symptoms of serotonin syndrome include: confusion, agitation, fever, sweating, uncoordinated movements of the limbs or eyes, uncontrolled muscle movements, or diarrhea.
  • If you are taking St. John's Wort (Hypericum perforatum) preparations, as they may increase the likelihood of side effects.

Almotriptán should not be taken at the same time as other medications that contain ergotamine, which are also used to treat migraines. However, both medications can be taken one after the other, provided that a minimum amount of time has passed between doses:

  • After taking almotriptán, it is recommended to wait at least 6 hours before taking ergotamine.
  • After taking ergotamine, it is recommended to wait at least 24 hours before taking almotriptán.

Pregnancy and breastfeeding

If you are pregnant or breastfeeding, think you may be pregnant, or plan to become pregnant, consult your doctor or pharmacist before using this medication.

There is only limited information available on the use of almotriptán during pregnancy. Almotriptán cinfa should only be used during pregnancy if prescribed by your doctor and after carefully considering the balance of benefits and risks.

Cautious use is recommended when using this medication during breastfeeding. You should avoid breastfeeding during the 24 hours following treatment.

Driving and using machines

This medication, like migraines, can cause drowsiness. If you notice these effects, avoid driving or using machines, as it may be dangerous.

almotriptán cinfa contains sodium

This medication contains less than 23 mg of sodium (1 mmol) per tablet; this is essentially "sodium-free".

3. How to take almotriptán cinfa

Follow the administration instructions for this medication exactly as indicated by your doctor or pharmacist. If you are unsure, consult your doctor or pharmacist again.

Almotriptán cinfa should only be used to treat a migraine attack that has already occurred and not to prevent migraine attacks or headaches.

Adults (18-65 years old)

The recommended dose is one 12.5 mg tablet of almotriptán, which should be taken as soon as possible after the onset of a migraine attack. If the attack does not subside, do not take more than one tablet.

If you experience a second attack within the next 24 hours, you can take a second 12.5 mg tablet, but only if at least 2 hours have passed between the first and second tablets.

The maximum daily dose is two 12.5 mg tablets in 24 hours.

The tablets can be taken with liquid (e.g., water) and can be taken with or without food. Almotriptán cinfa should be taken as soon as possible after the onset of a migraine attack, although it is also effective if taken later.

Severe kidney problems

If you have severe kidney problems, do not take more than one 12.5 mg tablet in 24 hours.

If you take more almotriptán cinfa than you should

In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicology Information Service, phone 91 562 04 20, indicating the medication and the amount ingested.

If you forget to take almotriptán cinfa

Try to take this medication as prescribed. Do not take a double dose to make up for forgotten doses.

If you have any other questions about the use of this medication, ask your doctor, pharmacist, or nurse.

Medicine questions

Started taking the medicine and have questions?

Discuss your symptoms and treatment with a doctor online.

4. Possible side effects

Like all medications, this medication can cause side effects, although not everyone will experience them.

Common (may affect up to 1 in 10 people)

  • Dizziness.
  • Drowsiness.
  • Nausea.
  • Vomiting.
  • Fatigue.

Uncommon (may affect up to 1 in 100 people)

  • Feeling of tingling, itching, or numbness of the skin (paresthesia).
  • Headache.
  • Ringing, noises, clicking (tinnitus).
  • Strong heartbeat (palpitations).
  • Throat tightness.
  • Diarrhea.
  • Discomfort when digesting food (dyspepsia).
  • Dry mouth.
  • Muscle pain (myalgia).
  • Bone pain.
  • Chest pain.
  • Feeling of weakness (asthenia).

Very rare (may affect up to 1 in 10,000 people)

  • Spasm of the coronary blood vessels (coronary vasospasm).
  • Heart attack (myocardial infarction).
  • Increased heart rate (tachycardia).

Frequency not known (cannot be estimated from available data)

  • Allergic reactions (hypersensitivity reactions), including swelling of the mouth, neck, or hands (angioedema).
  • Severe allergic reactions (anaphylactic reactions).
  • Seizures.
  • Visual disturbances, blurred vision (visual disturbances can also occur during a migraine attack itself).
  • Spasm of the blood vessels of the intestine, which can cause lack of blood flow and damage to the intestine. You may experience abdominal pain and bloody diarrhea.

During treatment with almotriptán cinfa, inform your doctor immediately:

  • If you experience chest pain, tightness in the chest or throat, or any other symptoms that may indicate a heart attack. Please inform your doctor immediately and do not take any more almotriptán cinfa tablets.

Reporting side effects

If you experience any side effects, consult your doctor or pharmacist, even if they are not mentioned in this package leaflet. You can also report them directly through the Spanish Medicines Monitoring System: https://www.notificaram.es. By reporting side effects, you can help provide more information on the safety of this medication.

5. Storage of almotriptán cinfa

Keep this medication out of sight and reach of children.

Do not use this medication after the expiration date stated on the packaging, after EXP.

The expiration date is the last day of the month indicated.

This medication does not require special storage conditions.

Medications should not be disposed of through wastewater or household waste. Dispose of packaging and unused medications at the pharmacy's SIGRE collection point. If you are unsure, ask your pharmacist how to dispose of packaging and unused medications. This will help protect the environment.

6. Contents of the pack and further information

Composition of almotriptán cinfa

  • The active ingredient is almotriptán. Each film-coated tablet contains 12.5 mg of almotriptán as almotriptán malate.
  • The other ingredients are:
    • Core of the tablet: mannitol, microcrystalline cellulose, povidone, sodium carboxymethyl starch (type A) (potato), and sodium stearyl fumarate.
    • Coating of the tablet: hypromellose (E-464), titanium dioxide (E-171), and macrogol 400.

Appearance of the product and contents of the pack

Almotriptán cinfa are film-coated tablets, white, circular, and biconvex.

They are available in ALU/ALU or PVC/ALU blisters.

Each pack contains 3, 4, 6, or 9 film-coated tablets.

Not all pack sizes may be marketed.

Marketing authorization holder and manufacturer

Marketing authorization holder

Laboratorios Cinfa, S.A.

Carretera Olaz-Chipi, 10. Polígono Industrial Areta

31620 Huarte (Navarra) - Spain

Manufacturer

Galenicum Health S.L.U.

Sant Gabriel, 50, Esplugues de Llobregat,

08950, Barcelona (Spain)

or

Laboratorios Cinfa, S.A.

Carretera Olaz-Chipi, 10. Polígono Industrial Areta

31620 Huarte (Navarra) - Spain

Date of the last revision of this package leaflet:June 20, 2021

Detailed information about this medication is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es/

You can access detailed and updated information about this medication by scanning the QR code included in the package leaflet and carton with your smartphone. You can also access this information at the following internet address: https://cima.aemps.es/cima/dochtml/p/78686/P_78686.html

QR code to: https://cima.aemps.es/cima/dochtml/p/78686/P_78686.html

Online doctors for ALMOTRIPTAN CINFA 12.5 mg FILM-COATED TABLETS

Discuss questions about ALMOTRIPTAN CINFA 12.5 mg FILM-COATED TABLETS, including use, safety considerations and whether a prescription is appropriate, subject to medical assessment and local regulations.

Doctor
5.0(38)

Andrei Popov

General medicinePain medicine7 years of experience
Licence no. 464628925

Dr. Andrei Popov is a General Practitioner with specialized training in chronic pain. He provides online consultations for adult patients in Spain and other European countries.

Dr. Popov understands that seeking help with weight-related concerns or pain that has persisted for months can be difficult. Many patients come to him after trying different approaches without feeling truly heard. During the consultation, the doctor creates a comfortable and supportive, non-judgmental environment where the patient’s medical history can be discussed in detail, questions can be answered, and the next steps can be decided together.

Weight Management and Metabolic Health

Dr. Popov can help assess overweight, obesity, and related conditions such as hypertension, diabetes, or metabolic disorders. During the consultation, the patient’s medical history, test results, current medications, and previous treatments will be reviewed.

If you would like to learn about possible medication options or have already started treatment, the doctor can assess your situation, review the effectiveness and tolerability of the therapy, and clearly explain its benefits, potential risks, and alternatives.

Not every patient requires the same treatment. A consultation does not guarantee a prescription — it provides an objective medical assessment and a plan tailored to your individual situation.

Pain and General Medicine

You can also consult Dr. Popov regarding:

* chronic pain, migraines, neuralgia, and fibromyalgia;

* back, neck, lower back, or joint pain;

* hypertension, diabetes, and follow-up of chronic conditions;

* review of test results, medical reports, and current treatment;

* preventive medicine and a second medical opinion.

How the Consultation Works

The video consultation lasts up to 30 minutes. The doctor will listen carefully, review the information you provide, and explain the next steps in clear and understandable language.

If additional tests, an in-person consultation, or urgent medical care are required, the doctor will inform you directly.

Dr. Popov’s goal is to make sure the patient feels heard and leaves the consultation with a clear understanding of their condition and the next steps they can take.

Book a video appointment
€86
Doctor
5.0(12)

Yevgen Yakovenko

General medicine12 years of experience
Licence no. 35/35/09707

Dr. Yevgen Yakovenko is a licensed surgeon and general practitioner in Spain and Germany. He specialises in general, paediatric, and oncological surgery, internal medicine, and pain management. He offers online consultations for adults and children, combining surgical precision with therapeutic support. Dr Yakovenko works with patients across different countries and provides care in Ukrainian, Russian, English, and Spanish.

Areas of medical expertise:

  • Acute and chronic pain: headaches, muscle and joint pain, back pain, abdominal pain, postoperative pain. Identifying the cause, selecting treatment, and creating a care plan.
  • Internal medicine: heart, lungs, gastrointestinal tract, urinary system. Management of chronic conditions, symptom control, second opinions.
  • Pre- and postoperative care: risk assessment, decision-making support, follow-up after surgery, rehabilitation strategies.
  • General and paediatric surgery: hernias, appendicitis, congenital conditions, both planned and urgent surgeries.
  • Injuries and trauma: bruises, fractures, sprains, soft tissue damage, wound care, dressing, referral when in-person care is required.
  • Oncological surgery: diagnosis review, treatment planning, and long-term follow-up.
  • Obesity treatment and weight management: a medical approach to weight loss, including assessment of underlying causes, evaluation of comorbidities, development of a personalised plan (nutrition, physical activity, pharmacotherapy if needed), and ongoing progress monitoring.
  • Imaging interpretation: analysis of ultrasound, CT, MRI, and X-ray results, surgical planning based on imaging data.
  • Second opinions and medical navigation: clarifying diagnoses, reviewing current treatment plans, helping patients choose the best course of action.

Experience and qualifications:

  • 12+ years of clinical experience in university hospitals in Germany and Spain.
  • International education: Ukraine – Germany – Spain.
  • Member of the German Society of Surgeons (BDC).
  • Certified in radiological diagnostics and robotic surgery.
  • Active participant in international medical conferences and research.

Dr Yakovenko explains complex topics in a clear, accessible way. He works collaboratively with patients to analyse health issues and make evidence-based decisions. His approach is grounded in clinical excellence, scientific accuracy, and respect for each individual.

If you are unsure about a diagnosis, preparing for surgery, or want to discuss your test results – Dr Yakovenko will help you evaluate your options and move forward with confidence.

Book a video appointment
€72
Doctor
5.0(3)

Lina Travkina

General medicine13 years of experience

Dr. Lina Travkina is a licensed family and preventive medicine doctor based in Italy. She provides online consultations for adults and children, supporting patients across all stages of care – from acute symptom management to long-term health monitoring and prevention.Areas of medical care include:

  • Respiratory conditions: colds, flu, acute and chronic bronchitis, mild to moderate pneumonia, bronchial asthma.

  • ENT and eye conditions: sinusitis, tonsillitis, pharyngitis, otitis, infectious and allergic conjunctivitis.

  • Digestive issues: gastritis, acid reflux (GERD), IBS, dyspepsia, bloating, constipation, diarrhoea, functional bowel symptoms, intestinal infections.

  • Urological and infectious diseases: acute and recurrent cystitis, bladder and kidney infections, prevention of recurrent UTIs, asymptomatic bacteriuria.

  • Chronic conditions: hypertension, diabetes, hypercholesterolemia, metabolic syndrome, thyroid disorders, excess weight.

  • Neurological and general symptoms: headache, migraine, dizziness, fatigue, sleep disturbances, reduced concentration, anxiety, asthenia.

  • Chronic pain support: back, neck, joint, and muscle pain, tension syndromes, pain associated with osteochondrosis and chronic conditions.

Additional care areas:

  • Preventive consultations and check-up planning.

  • Medical advice and follow-up consultations.

  • Test interpretation and diagnostic guidance.

  • Structured support for undiagnosed complaints.

  • Second opinion on diagnoses and treatment plans.

  • Nutritional and lifestyle support for vitamin deficiencies, anaemia, metabolic issues.

  • Post-operative recovery support and pain management.

  • Preconception counselling and postpartum support.

  • Immunity support and strategies to reduce frequency of infections.

Dr. Travkina combines evidence-based medicine with an attentive, personalised approach. Her consultations focus not only on treatment, but also on prevention, recovery, and long-term wellbeing.If during the consultation it becomes clear that your case requires in-person assessment or specialised care outside of her scope, the session will be terminated and the payment fully refunded.

Book a video appointment
€75
Doctor
5.0(21)

Nuno Tavares Lopes

General medicine18 years of experience

Dr. Nuno Tavares Lopes is a licensed physician in Portugal with 17 years of experience in emergency medicine, family and general practice, and public health. He is the Director of Medical and Public Health Services at an international healthcare network and serves as an external consultant for the WHO and ECDC.

  • Emergency care: infections, fever, chest/abdominal pain, minor injuries, paediatric emergencies

  • Family medicine: hypertension, diabetes, cholesterol, chronic disease management

  • Travel medicine: pre-travel advice, vaccinations, fit-to-fly certificates, travel-related illnesses

  • Sexual and reproductive health: PrEP, STD prevention, counselling, treatment

  • Weight management and wellness: personalised weight loss programmes, lifestyle guidance

  • Skin and ENT issues: acne, eczema, allergies, rashes, sore throat, sinusitis

  • Pain management: acute and chronic pain, post-surgical care

  • Public health: prevention, health screenings, long-term monitoring

  • Sick leave (Baixa médica) connected to Segurança Social in Portugal

  • IMT medical certificates for driving licence exchange

Dr. Nuno Tavares Lopes provides medical support for patients using GLP-1 medications (Mounjaro, Wegovy, Ozempic, Rybelsus) as part of a weight loss strategy. He offers individualised treatment planning, regular follow-up, dose adjustment, and advice on combining medication with sustainable lifestyle changes. Consultations follow the medical standards accepted in Europe.Dr. Lopes also provides interpretation of medical tests, follow-up care for complex patients, and multilingual support. Whether for urgent concerns or long-term care, he helps patients act with clarity and confidence.

Book a video appointment
€70

Frequently Asked Questions

ALMOTRIPTAN CINFA 12.5 mg FILM-COATED TABLETS requires a prescription in Spain. You can check with a doctor online whether this medicine may be appropriate for your situation.

The active ingredient in ALMOTRIPTAN CINFA 12.5 mg FILM-COATED TABLETS is almotriptan. This information helps identify medicines with the same composition but different brand names.

The average pharmacy price for ALMOTRIPTAN CINFA 12.5 mg FILM-COATED TABLETS is around 19.53 EUR. Prices may vary depending on the manufacturer and dosage form.

ALMOTRIPTAN CINFA 12.5 mg FILM-COATED TABLETS is manufactured by Laboratorios Cinfa S.A.. Pharmacy brands and packaging may differ depending on the distributor.

Doctors such as Family doctors, Psychiatrists, Dermatologists, Cardiologists, Endocrinologists, Gastroenterologists, Pulmonologists, Nephrologists, Rheumatologists, Hematologists, Infectious disease physicians, Allergists, Geriatricians, Paediatricians, Oncologists may assess whether ALMOTRIPTAN CINFA 12.5 mg FILM-COATED TABLETS is appropriate, depending on your situation and local regulations. You can book an online consultation to discuss your symptoms and possible next steps.

The prescription is issued by a doctor after assessing your health. In Spain, ALMOTRIPTAN CINFA 12.5 mg FILM-COATED TABLETS is then dispensed in pharmacies with that prescription. An online consultation does not guarantee that a prescription will be issued: the decision always rests with the doctor.

To request an assessment, you can use Oladoctor:

Other medicines with the same active substance (almotriptan) include ALMOGRAN 12.5 mg FILM-COATED TABLETS, ALMOTRIPTAN COMBIX 12.5 mg FILM-COATED TABLETS, ALMOTRIPTAN KERN PHARMA 12.5 mg FILM-COATED TABLETS. These may have different brand names or formulations but contain the same therapeutic ingredient. Always consult a doctor before switching or starting a new medicine.

Stay informed about Oladoctor

News about new services, product updates and useful information for patients.

Follow us on social media